Literature DB >> 1206123

Heparin neutralizing activity test in the diagnosis of acute myocardial infarction.

J R O'Brien, M Etherington, S Jamieson, P Lawford, J Sussex, S V Lincoln.   

Abstract

We have previously shown in patients after recovery from a myocardial infarct (post-MI) that the heparin neutralizing activity (HNA) in the plasma is raised and that this activity may come from platelet factor 4 derived from activated platelets. This report concerns 89 patients admitted with acute chest pain; in 54, with evidence of acute infarction, the level of HNA is much higher than in a post-MI group or controls. Over the ensuing weeks the HNA decreases to the post-MI level. In 34 patients the evidence subsequently collected excluded a diagnosis of infarction; in these there were almost always normal amounts of HNA and little overlap with the results from the patients with infarcts. This easy test is therefore likely to prove clinically useful. Its significance is discussed. The platelet count and platelet volume are both abnormal in patients with acute infarction and also in the chest pain group so these tests do not help to discriminate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206123      PMCID: PMC475917          DOI: 10.1136/jcp.28.12.975

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Reduction of heparin activity by plasma globulins in patients with increased heparin resistance.

Authors:  T HOLGER-MADSEN
Journal:  Acta Haematol       Date:  1962       Impact factor: 2.195

2.  A technique for the heparin-tolerance test.

Authors:  J GORMSEN
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

3.  CHANGES IN BLOOD COAGULATION FOLLOWING CORONARY THROMBOSIS MEASURED BY THE HEPARIN RETARDED CLOTTING TEST (WAUGH AND RUDDICK TEST).

Authors:  J H Ogura; N R Fetter; M A Blankenhorn; H I Glueck
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

4.  Acceleration of blood coagulation in acute myocardial infarction as demonstrated by the heparin clotting time; effect of dicumarol therapy.

Authors:  R L ROSENTHAL; J C WEAVER; A BENEDEK
Journal:  Circulation       Date:  1952-08       Impact factor: 29.690

5.  Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states.

Authors:  R Farbiszewski; S Niewiarowski; K Worowski; B Lipiński
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

6.  Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.

Authors:  J R O'Brien
Journal:  Thromb Diath Haemorrh       Date:  1974-09-30

7.  Letter: Heparin thrombin clotting-time and platelet factor 4.

Authors:  J R O'Brien; M Etherington; S Jamieson; P Lawford
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

8.  Platelet consumption in chronically induced plasma platelet factor 4-like activity reflecting rate of intravascular coagulation in dogs.

Authors:  V Fuster; E J Bowie; F J Kazmier; C A Owen
Journal:  Thromb Res       Date:  1974-02       Impact factor: 3.944

9.  Platelet function long after arterial and venous thrombosis.

Authors:  J R O'Brien; M Etherington; S Jamieson; M R Klaber; S V Lincoln
Journal:  Thromb Diath Haemorrh       Date:  1974-05-15

10.  Inter-relationships between platelet response to adenosine diphosphate, blood coagulation and serum lipids in patients with peripheral occlusive atherosclerosis.

Authors:  R C Cotton; K Bloor; G Archibald
Journal:  Atherosclerosis       Date:  1972 Nov-Dec       Impact factor: 5.162

  10 in total
  5 in total

1.  Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys.

Authors:  J W Yarnell; P M Sweetnam; S Rogers; P C Elwood; D Bainton; I A Baker; R Eastham; J R O'Brien; M D Etherington
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

2.  Changes in the heparin neutralising activity of platelet poor plasma after immunisation.

Authors:  I A Baker; C H Howells; J R O'Brien
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

3.  Haemostatic factors and ischaemic heart disease. The Caerphilly study.

Authors:  J W Yarnell; P M Sweetnam; P C Elwood; R Eastham; R A Gilmour; J R O'Brien; M D Etherington
Journal:  Br Heart J       Date:  1985-05

Review 4.  Platelet markers of thromboembolic disease.

Authors:  H Wohl
Journal:  West J Med       Date:  1981-07

5.  Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.

Authors:  I A Baker; R Eastham; P C Elwood; M Etherington; J R O'Brien; P M Sweetnam
Journal:  Br Heart J       Date:  1982-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.